POSEIDA THERAPEUTICS INC shareholders Q3 2023

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 86 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

POSEIDA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 3,567,985$8,491,8042.58%
Aisling Capital Management LP 1,043,267$2,482,9751.02%
Atom Investors LP 156,168$371,6800.08%
Pentwater Capital Management LP 5,975,000$14,220,5000.08%
CORNERCAP INVESTMENT COUNSEL INC 79,709$189,7070.04%
Forefront Analytics, LLC 24,969$59,4280.03%
Callan Capital, LLC 76,559$182,2100.02%
XTX Topco Ltd 40,782$97,0610.02%
Advisory Services Network, LLC 257,271$612,3050.02%
RBF Capital, LLC 70,171$167,0070.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 191,800$456,4840.01%
FNY Investment Advisers, LLC 7,500$170.01%
MCF Advisors LLC 42,854$101,9930.01%
ACADIAN ASSET MANAGEMENT LLC 851,839$2,0250.01%
BLAIR WILLIAM & CO/IL 740,650$1,762,7470.01%
Keystone Financial Group 15,000$35,7000.01%
Connor, Clark & Lunn Investment Management Ltd. 342,857$816,0000.00%
MILLENNIUM MANAGEMENT LLC 2,554,172$6,078,9290.00%
CENTRAL BANK & TRUST CO 7,608$18,0300.00%
Renaissance Technologies 783,071$1,8640.00%
External links

This page lists POSEIDA THERAPEUTICS INC's shareholders in Q3 2023. To view POSEIDA THERAPEUTICS INC's shareholder history, click here.